Could Thalidomide Be a Treatment Option for Arteriovenous Malformations?

World Neurosurg. 2017 Mar:99:802. doi: 10.1016/j.wneu.2016.10.068.

Authors

Daniele Bongetta¹, Cesare Zoia², Elvis Lafe³, Paolo Gaetani²

Affiliations

¹ Neurosurgery Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, Università degli Studi di Pavia, Pavia, Italy. Electronic address: danielebongetta@hotmail.com.
² Neurosurgery Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
³ Neuroradiology Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.

PMID: 28314250
DOI: 10.1016/j.wneu.2016.10.068

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors
Arteriovenous Malformations*
Humans
Thalidomide*

Substances

Angiogenesis Inhibitors
Thalidomide